Huvepharma EOOD, a global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products, and Intrexon Corp., a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, announced that they have entered into a research collaboration agreement.
The collaboration represents the first commercial application of Intrexon's proprietary fungal expression platform to produce a new animal
All access premium subscription
This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.
Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)
Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.
SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx
TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx